(Q43256423)

English

Physicochemical stability of oxaliplatin in 5% dextrose injection stored in polyvinyl chloride, polyethylene, and polypropylene infusion bags

scientific article published in November 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Physicochemical stability of oxaliplatin in 5% dextrose injection stored in polyvinyl chloride, polyethylene, and polypropylene infusion bags (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

1 reference

based on heuristic

inferred from title

author name string

Céline Eiden

1

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Laurent Philibert

2

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Khedidja Bekhtari

3

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Sylvain Poujol

4

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Francoise Malosse

5

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Frédéric Pinguet

6

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

publication date

1 November 2009

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

American Journal of Health-System Pharmacy

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

66

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

1929-1933

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Randomized controlled trial of reduced-dose bolus fluorouracil plus leucovorin and irinotecan or infused fluorouracil plus leucovorin and oxaliplatin in patients with previously untreated metastatic colorectal cancer: a North American Intergroup Tri

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090039

31 March 2020

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090039

31 March 2020

Clinical aspects and molecular basis of oxaliplatin neurotoxicity: current management and development of preventive measures

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090039

31 March 2020

Oxaliplatin degradation in the presence of chloride: identification and cytotoxicity of the monochloro monooxalato complex

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090039

31 March 2020

Carboplatin and oxaliplatin decomposition in chloride medium, monitored by XAS.

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090039

31 March 2020

EXAFS characterization of oxaliplatin anticancer drug and its degradation in chloride media

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090039

31 March 2020

Stability of oxaliplatin in infusion bags containing 5% dextrose injection

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090039

31 March 2020

Stability of oxaliplatin solution

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090039

31 March 2020

Identifiers

10.2146/AJHP090039

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43256423&oldid=1985018405"